Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Become a Deals+Insights member to read Mounjaro v Wegovy — what does the weight loss drug race mean for investors? Find out more

HBI Deals+Insights / News

Mounjaro v Wegovy — what does the weight loss drug race mean for investors?

In the first head-to-head trial comparing two popular weight loss drugs, Mounjaro (tirzepatide) was found to be more effective than competitor Wegovy (semaglutide).

If you are a member please login to continue reading

Get a membership to access premium content

We help businesses in the health care services sector stay ahead of the competition, make the right connections, unlock business growth and make well informed decisions. Here’s how

Exclusive news and strategic insights from across Europe and emerging markets.
The latest M&A stories, interviews with industry leaders and a searchable archive of more than 7,000 news articles.

Get in touch to find out which membership is right for you

Or upgrade to include the world's most comprehensive data on European and Emerging Market private operators

Market Reports and data about EMEA health care markets across 23 sub-sectors in more than 100 countries. Operator Database of more than 4,500 health care service companies. Investor Database with details of over 2,000 investments. Plus, everything included in Deals+Insights.

Get in touch to find out which membership is right for you

Unsure on which membership is right for you?
Please get in touch with us today.

Call our experts on +00 44 207 183 3779 or email
us at [email protected]

Get a membership to access premium content

Unsure on which membership is right for you?Please get in touch with us today.

Proud to be trusted by 18,727 leading health care businesses, including

Our Services

Company

Resources

Our Services

Company

Resources

Find Us

Please wait while your search results are being generated.

Get a CLEAR picture on private healthcare services across Europe

Subscribe now to Healthcare Europa and get instant access to:

check

check

check

check

check

check

check

check

Know the pulse of the market from just £1040.

Get a CLEAR picture on private healthcare services across Emerging Markets

Subscribe now to Healthcare Nova and get instant access to:

check

check

check

check

check

check

check

check

Know the pulse of the market from just £1040.

Get a CLEAR picture of ALL the top players in 22 sectors across 34 countries

Subscribe now to the only database of the Top 1,700 operators in Europe. Use it to:

check

check

check

check

check

Instant access plus ongoing updatesfrom £1,895.

Get a CLEAR picture of the Top 1,300 players in Emerging Markets

Subscribe now to the only database of the Top 1,300 private healthcare operators in Emerging Markets . Use it to:

check

check

check

check

check

check

Instant access plus ongoing updatesfrom £1,895.

Unsure on which membership is right for you?
Please get in touch with us today.

Know the pulse of the market
from just £1040.

Know the pulse of the market
from just £1040.

Subscribe now to the only database of the
Top 1,700 operators in Europe. Use it to:

Instant access plus ongoing updates
from £1,895.

Subscribe now to the only database of the Top 1,300 private
healthcare operators in Emerging Markets . Use it to:

Instant access plus ongoing updates
from £1,895.